Theranexus (France) Market Value

ALTHX Stock  EUR 1.09  0.02  1.87%   
Theranexus' market value is the price at which a share of Theranexus trades on a public exchange. It measures the collective expectations of Theranexus SA investors about its performance. Theranexus is selling at 1.09 as of the 23rd of July 2025; that is 1.87% up since the beginning of the trading day. The stock's last reported lowest price was 1.04.
With this module, you can estimate the performance of a buy and hold strategy of Theranexus SA and determine expected loss or profit from investing in Theranexus over a given investment horizon. Check out Theranexus Correlation, Theranexus Volatility and Theranexus Alpha and Beta module to complement your research on Theranexus.
Symbol

Please note, there is a significant difference between Theranexus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theranexus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theranexus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Theranexus 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Theranexus' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Theranexus.
0.00
04/24/2025
No Change 0.00  0.0 
In 3 months and 1 day
07/23/2025
0.00
If you would invest  0.00  in Theranexus on April 24, 2025 and sell it all today you would earn a total of 0.00 from holding Theranexus SA or generate 0.0% return on investment in Theranexus over 90 days. Theranexus is related to or competes with Abivax SA, Sensorion, Gensight Biologics, and Transgene. Theranexus socit anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous sys... More

Theranexus Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Theranexus' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Theranexus SA upside and downside potential and time the market with a certain degree of confidence.

Theranexus Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Theranexus' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Theranexus' standard deviation. In reality, there are many statistical measures that can use Theranexus historical prices to predict the future Theranexus' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Theranexus' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.051.0919.35
Details
Intrinsic
Valuation
LowRealHigh
0.040.8619.12
Details
Naive
Forecast
LowNextHigh
0.020.8019.07
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.151.151.84
Details

Theranexus SA Backtested Returns

Theranexus is out of control given 3 months investment horizon. Theranexus SA owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14 % return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 2.56% are justified by taking the suggested risk. Use Theranexus SA Coefficient Of Variation of 702.22, semi deviation of 4.58, and Risk Adjusted Performance of 0.138 to evaluate company specific risk that cannot be diversified away. Theranexus holds a performance score of 11 on a scale of zero to a hundred. The entity has a beta of -2.13, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Theranexus are expected to decrease by larger amounts. On the other hand, during market turmoil, Theranexus is expected to outperform it. Use Theranexus SA accumulation distribution, price action indicator, as well as the relationship between the potential upside and jensen alpha , to analyze future returns on Theranexus SA.

Auto-correlation

    
  0.66  

Good predictability

Theranexus SA has good predictability. Overlapping area represents the amount of predictability between Theranexus time series from 24th of April 2025 to 8th of June 2025 and 8th of June 2025 to 23rd of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Theranexus SA price movement. The serial correlation of 0.66 indicates that around 66.0% of current Theranexus price fluctuation can be explain by its past prices.
Correlation Coefficient0.66
Spearman Rank Test0.62
Residual Average0.0
Price Variance0.02

Theranexus SA lagged returns against current returns

Autocorrelation, which is Theranexus stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Theranexus' stock expected returns. We can calculate the autocorrelation of Theranexus returns to help us make a trade decision. For example, suppose you find that Theranexus has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Theranexus regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Theranexus stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Theranexus stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Theranexus stock over time.
   Current vs Lagged Prices   
       Timeline  

Theranexus Lagged Returns

When evaluating Theranexus' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Theranexus stock have on its future price. Theranexus autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Theranexus autocorrelation shows the relationship between Theranexus stock current value and its past values and can show if there is a momentum factor associated with investing in Theranexus SA.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Theranexus Stock Analysis

When running Theranexus' price analysis, check to measure Theranexus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theranexus is operating at the current time. Most of Theranexus' value examination focuses on studying past and present price action to predict the probability of Theranexus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theranexus' price. Additionally, you may evaluate how the addition of Theranexus to your portfolios can decrease your overall portfolio volatility.